Back to Stakeholders
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchUniversities and Colleges without Dedicated Psychedelic Research Groups
Research, Drug Development & Manufacturing

University of Maryland, Baltimore

2 Trials

The University of Maryland, Baltimore (UMB) is Maryland’s public health and professional sciences university, housing schools of medicine, pharmacy, dentistry, nursing, law, and social work. UMB’s School of Medicine participates in clinical trials investigating psychedelic-assisted therapies including psilocybin for depression and ketamine-based treatments for psychiatric conditions.

Academic Research

0 papers

Published Papers

0

Trial Involvement

2

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
hospital
Website
Visit

Sponsored Trials

2
RecruitingII

Ketamine for Opioid Use Disorder

Start Date
Compounds
Ketamine, Placebo
TerminatedI

Ketamine for OUD and Comorbid Depression (OUDCD)

Start Date
Compounds
Ketamine